Bath & Body Works, Inc. (NYSE: BBWI) Faces Challenges Amidst Downgrade and Legal Issues

Core Insights - Bath & Body Works, Inc. (NYSE:BBWI) is a prominent retailer in the personal care and home fragrance sector, competing with brands like The Body Shop and Lush [1] Business Performance - Citigroup downgraded BBWI from a "Buy" to a "Neutral" rating on February 17, 2026, due to concerns over a "weak" core business, with the stock priced at $24.07 at that time [2] - BBWI's stock has shown resilience, currently priced at $24.07, reflecting a 5.29% increase or $1.21, despite significant volatility over the past year [4][6] - The stock has fluctuated between a low of $22.88 and a high of $24.17 on the current day, with a yearly high of $41.87 and a low of $14.28 [4] Legal Issues - The Schall Law Firm has initiated a class action lawsuit against Bath & Body Works for alleged violations of the Securities Exchange Act of 1934, targeting investors who purchased BBWI securities between June 4, 2024, and November 19, 2025 [3] - This legal action could negatively impact investor confidence and the company's stock performance [3] Market Metrics - BBWI's market capitalization is approximately $4.96 billion, with a trading volume of 4,802,874 shares on the NYSE, indicating strong interest in the stock despite ongoing legal issues and business concerns [5]